Transglutaminase activation in neurodegenerative diseases. - Wikidata - wikimedia - TriplyDB

Transglutaminase activation in neurodegenerative diseases.

Transglutaminase activation in neurodegenerative diseases.

http://www.wikidata.org/entity/Q37352964

about

Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional protein Transglutaminase 6: a protein associated with central nervous system development and motor function.Transglutaminase regulation of cell function.TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing.γ-Glutamylamines and neurodegenerative diseases The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.Potential of transglutaminase 2 as a therapeutic target.Critical Evaluation of the Changes in Glutamine Synthetase Activity in Models of Cerebral Stroke.Microglia Endocytose Amyloid β Through the Binding of Transglutaminase 2 and Milk Fat Globule EGF Factor 8 Protein.Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes.Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1.Mutations in TGM6 induce the unfolded protein response in SCA35.Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.Transglutaminases Derived from Astrocytes Accelerate Amyloid β Aggregation.Cystamine and cysteamine as inhibitors of transglutaminase activity

P2860

Q28247511-BD64F9CE-D521-4D24-AAB2-FBFE3D3AAC81 Q30155456-0CD55760-931C-4D54-BB22-5C9248F59E46 Q33707936-430520F9-3B22-433D-A959-CA31D131D087 Q34151711-785C91F3-4DDD-46E1-9E24-501AF1B8C208 Q36377238-64785A54-2EDC-408B-B9AB-E88736936D04 Q36884822-D57373A4-661E-497C-BB22-FCC301A71BCF Q37776508-6F503934-5DF6-4ADB-94D5-6128CB369DD5 Q38558969-E06698A1-125D-457A-8D68-05DD027E6E6A Q38705118-EEC56E6E-15A9-4A17-A653-97F3CC231DA3 Q38857583-A75361D2-07C4-48D0-B4A7-D3B0EB53D2CF Q43615099-482B5EC2-3B9A-4799-88ED-E2EDE9DDF6F4 Q47767397-EEFF4886-15CF-4026-97B2-E9937F5A8949 Q48273330-D3CDE9E6-FC59-4D38-98FB-EB4F18B88C01 Q50740397-7D177A4E-A4A5-442E-A55D-A7D8BD878A9F Q58763905-8E610AFD-91C3-4AE6-AA4B-F6380B6E2822

P2860

Transglutaminase activation in neurodegenerative diseases.

http://www.wikidata.org/entity/Q37352964

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Transglutaminase activation in neurodegenerative diseases.

@en

Transglutaminase activation in neurodegenerative diseases.

@nl

type

label

Transglutaminase activation in neurodegenerative diseases.

@en

Transglutaminase activation in neurodegenerative diseases.

@nl

prefLabel

Transglutaminase activation in neurodegenerative diseases.

@en

Transglutaminase activation in neurodegenerative diseases.

@nl

P1433

Q37352964-D2069739-F733-45A0-B65B-A385509FB61C

P1476

Q37352964-69419EC2-082D-44F6-90EA-B8DD863A3D6D

P2093

Q37352964-235CF5B6-43C7-48DD-BA1E-ACE8864A11F4

Q37352964-DE40EE5B-327A-45D4-A363-28D1555F2D00

P2860

Q37352964-00E59420-E7DC-43A1-9572-ADDC26CB7089

Q37352964-0136ABE4-2038-4581-902A-48BE2D8DC64D

Q37352964-0226B599-0359-4E44-B4C1-EF5485E28826

Q37352964-0570E063-00EA-4353-8253-ED509B133C51

Q37352964-059B30B0-523E-4086-B6B8-38A0EA244DD1

Q37352964-05E16A61-7AD5-40BA-95F0-5DBDA2DFECC9

Q37352964-0A5C6D3D-2139-4354-A5A9-3535381C9F2B

Q37352964-0A7527B2-9404-4579-B9F8-A21E605E703E

Q37352964-0B1C5EEE-E714-4288-AC70-18C917AE7A3E

Q37352964-0C31455D-2599-4671-ADE4-DC616C0027E4

P304

Q37352964-9DB9D6A2-00FB-42DD-AE02-C176720811C8

P31

Q37352964-31E9BD8E-7914-4F17-8178-E9E1F0E54970

P356

Q37352964-ABA20AD8-D276-466A-A512-A8BFA0983C58

P433

Q37352964-0808121B-9675-4AA1-B9E1-F0E2036A2C46

P478

Q37352964-79CA1F3F-37BA-407B-8C51-A622F12B368C

P50

Q37352964-5AD469C1-09F0-4DA7-A3BF-836813C535BF

Q37352964-E1FA9CD9-4E56-4DBF-A0C6-7C0052912EC3

P577

Q37352964-BD6CB0E9-AD54-46A3-A793-883B62084400

P5875

Q37352964-817893A3-9D8C-47BE-BE12-118B638D78E5

P698

Q37352964-B2ABB317-D6C0-4448-94B8-5FCEE5023C15

P921

Q37352964-F180E15C-7B0A-44BD-BB9F-480CF100F045

P932

Q37352964-1F187254-EAA6-4278-ADB5-D2B68AAA962C

P356

P1433

Future Neurology

P1476

Transglutaminase activation in neurodegenerative diseases

@en

P2093

Arthur Jl Cooper

http://www.w3.org/2001/XMLSchema#string

Thomas M Jeitner

http://www.w3.org/2001/XMLSchema#string

P2860

Transglutaminase 2 undergoes a large conformational change upon activation

The importance of neuritic plaques and tangles to the development and evolution of AD

Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain

Roles of calcium ions in the activation and activity of the transglutaminase 3 enzyme

Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations

Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1

The transglutaminase 1 enzyme is variably acylated by myristate and palmitate during differentiation in epidermal keratinocytes

Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1

Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.

P304

449-467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FNL.09.17

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Kevin P. Battaile

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41452846

http://www.w3.org/2001/XMLSchema#string

P698

20161049

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

2746681

http://www.w3.org/2001/XMLSchema#string